Pancreatic cancer: The Lancet: January 24, 2017
John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer.
Source: Listen to The Lancet - Category: General Medicine Authors: The Lancet Source Type: podcasts
More News: Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Pancreas | Pancreatic Cancer